Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (141-150 of 349) with videos related to

Pageof 35
Sort By:
Circulation|December 27, 2011
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR)Peter Damman, Lars Wallentin, Keith A A Fox, et al.
Journal of the American College of Cardiology|August 24, 2019
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|June 11, 2023
Remodeling dental anatomy vs sham therapy for chronic temporomandibular disorders. A placebo-controlled randomized clinical trialUrbano Santana-Penín, Urbano Santana-Mora, Alicia López-Solache, et al.
Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
European Journal of Heart Failure|May 22, 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)David Preiss, Dirk J van Veldhuisen, Naveed Sattar, et al.
Journal of the American College of Cardiology|March 19, 2021
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|May 30, 2021
Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trialMilton Packer, James L Januzzi, Joao Pedro Ferreira, et al.
European Heart Journal|July 5, 2022
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trialWolfram Doehner, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|January 22, 2024
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-PreservedTripti Rastogi, João Pedro Ferreira, Javed Butler, et al.
Pageof 35

Showing results (141-150 of 349) with videos related to

Sort By:
Pageof 35
Circulation|December 27, 2011
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR)Peter Damman, Lars Wallentin, Keith A A Fox, et al.
Journal of the American College of Cardiology|August 24, 2019
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|June 11, 2023
Remodeling dental anatomy vs sham therapy for chronic temporomandibular disorders. A placebo-controlled randomized clinical trialUrbano Santana-Penín, Urbano Santana-Mora, Alicia López-Solache, et al.
Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
European Journal of Heart Failure|May 22, 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)David Preiss, Dirk J van Veldhuisen, Naveed Sattar, et al.
Journal of the American College of Cardiology|March 19, 2021
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|May 30, 2021
Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trialMilton Packer, James L Januzzi, Joao Pedro Ferreira, et al.
European Heart Journal|July 5, 2022
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trialWolfram Doehner, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|January 22, 2024
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-PreservedTripti Rastogi, João Pedro Ferreira, Javed Butler, et al.
Pageof 35